Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET)

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Akhanoba, Folasade ^a   MacDougall, Jane ^a   Mathur, Raj ^a   Hassan, Wassim ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; CEFTRIAXONE; CORTICOSTEROID DERIVATIVE; ERYTHROMYCIN; FLUCONAZOLE; INTRALIPID; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANHYDRAMNIO; ANOREXIA; ARTHROPATHY; ARTICLE; BACKACHE; CANDIDA GLABRATA; CANDIDEMIA; CANDIDIASIS; CASE REPORT; CHILL; CHORIOAMNIONITIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOGRAPHY; EMBRYO TRANSFER; ENDOCARDITIS; ENDOPHTHALMITIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS MOVEMENT; FOLLOW UP; GESTATIONAL AGE; HEPATOSPLENOMEGALY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION RISK; MALAISE; MEMBRANE RUPTURE; MONOZYGOTIC TWINS; NEUTROPHIL COUNT; NONHUMAN; NULLIPARA; PELVIC EXAMINATION; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; RIGOR; SEPSIS; SIDE EFFECT; SPOTTING; TERTIARY HEALTH CARE; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY TRACT INFECTION;

EID: 84898646774     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-203202     Document Type: Article

References (23)

1. Joseph PB, John PE, Howard WK, et al. Candida chorioamnionitis diagnosed by amniocentesis with subsequent fetal infection. Rev Argent Microbiol 2006;38:9-12.
2. Potasman I, Leibovitz Z, Sharf M. Candida sepsis in pregnancy and the postpartum period. Rev Infect Dis 1991;13:146-9.
3. Jackel D, Lai K. Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilisation pregnancy: case report and review. Clin Infect Dis 2013;56:555-8.
4. Ibara AS, Marcorelles P, Le Martelot MT, et al. Two cases of systemic Candida glabrata infection following in vitro fertilisation and (Pubitemid 38187024)
5. Sfameni SF, Talbot JM, Chow SLS, et al. Candida glabrata chorioamnionitis following in vitro fertilisation and embryo transfer. Aust N Z J Obstet Gynaecol 1997;37:88-91. (Pubitemid 27091147)
6. Obehi A, Asemota MD, Nyirjesy P, et al. Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. Fertil Steril 2011;95:803.e1-2.
7. Lee KA, Koo JJ, Yoon TK, et al. Immunosuppression by corticosteroid has no effect on the pregnancy rate in routine in-vitro fertilization/embryo transfer patients. Hum Reprod 1994;9:1832-5. (Pubitemid 24322379)
8. Mottla GL, Smotrich DB, Gindoff PR, et al. Increasing clinical pregnancy rates after IVF/ET. Can immunosuppression help? J Reprod Med 1996;41:889-91. (Pubitemid 27020754)
9. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96. (Pubitemid 29055954)
10. Kalkanci A, Güzel AB, Khalil II, et al. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Med Mycol 2012;50:585-93.
11. Wenjin Q, Yifu S. Epidemiological study on vaginal Candida glabrata isolated from pregnant women. Scand J Infect Dis 2006;38:49-54. (Pubitemid 43123843)
12. Babic M, Hukic M. Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and non-pregnant women. Bosn J Basic Med Sci 2010;10:89-97.
13. Meizoso T, Rivera T, Fernandez-Acenero MJ, et al. Intrauterine candidiasis: report of four cases. Arch Gynecol Obstet 2008;278:173-6.
14. Krishnan L, Guilbert LJ, Wegmann TG, et al. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorption: correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 1996;156:653-62.
15. Thum MY, Bhaskaran S, Abdalla HI, et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004;19:2395-400. (Pubitemid 39406706)
16. Winger EE, Reed JL, Ashoush S, et al. Treatment with adalimumab. (humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009;61:113-20.
17. Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012;6. doi:10.1002/14651858. CD005996.pub3.
18. Taniguchi F. Results of prednisolone given to improve the outcome of in vitro fertilisation-embryo transfer in women with antinuclear antibodies. J Reprod Med 2005;50:383-8. (Pubitemid 40863953)
19. Ying Y, Zhong YP, Zhou CQ, et al. A retrospective study of IVF outcome in patients with anticardiolipin antibody: effect of methylprednisolone plus low-dose aspirin adjuvant treatment. J Reprod Immunol 2012;94:196-201.
20. Dean JL, Wolf JE, Ranzini AC, et al. Use of amphotericin B during pregnancy: case report and review. Clin Infect Dis 1994;18:364-8. (Pubitemid 24086306)
21. Pursley TJ, Blomquist IK, Abraham J, et al. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996;22:336-40. (Pubitemid 26056165)
22. Norgaard M, Pedersen L, Gislum M, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother 2008;62:172-6. (Pubitemid 351865893)
23. Al Eyadhy A, Razack S. The ethics of using innovative therapies in the care of children. Paediatr Child Health 2008;13:181-4. (Pubitemid 351678261)